Cargando…
Atypical chemokine receptor 4 shapes activated B cell fate
Activated B cells can initially differentiate into three functionally distinct fates—early plasmablasts (PBs), germinal center (GC) B cells, or early memory B cells—by mechanisms that remain poorly understood. Here, we identify atypical chemokine receptor 4 (ACKR4), a decoy receptor that binds and d...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839757/ https://www.ncbi.nlm.nih.gov/pubmed/29386231 http://dx.doi.org/10.1084/jem.20171067 |
_version_ | 1783304455632977920 |
---|---|
author | Kara, Ervin E. Bastow, Cameron R. McKenzie, Duncan R. Gregor, Carly E. Fenix, Kevin A. Babb, Rachelle Norton, Todd S. Zotos, Dimitra Rodda, Lauren B. Hermes, Jana R. Bourne, Katherine Gilchrist, Derek S. Nibbs, Robert J. Alsharifi, Mohammed Vinuesa, Carola G. Tarlinton, David M. Brink, Robert Hill, Geoffrey R. Cyster, Jason G. Comerford, Iain McColl, Shaun R. |
author_facet | Kara, Ervin E. Bastow, Cameron R. McKenzie, Duncan R. Gregor, Carly E. Fenix, Kevin A. Babb, Rachelle Norton, Todd S. Zotos, Dimitra Rodda, Lauren B. Hermes, Jana R. Bourne, Katherine Gilchrist, Derek S. Nibbs, Robert J. Alsharifi, Mohammed Vinuesa, Carola G. Tarlinton, David M. Brink, Robert Hill, Geoffrey R. Cyster, Jason G. Comerford, Iain McColl, Shaun R. |
author_sort | Kara, Ervin E. |
collection | PubMed |
description | Activated B cells can initially differentiate into three functionally distinct fates—early plasmablasts (PBs), germinal center (GC) B cells, or early memory B cells—by mechanisms that remain poorly understood. Here, we identify atypical chemokine receptor 4 (ACKR4), a decoy receptor that binds and degrades CCR7 ligands CCL19/CCL21, as a regulator of early activated B cell differentiation. By restricting initial access to splenic interfollicular zones (IFZs), ACKR4 limits the early proliferation of activated B cells, reducing the numbers available for subsequent differentiation. Consequently, ACKR4 deficiency enhanced early PB and GC B cell responses in a CCL19/CCL21-dependent and B cell–intrinsic manner. Conversely, aberrant localization of ACKR4-deficient activated B cells to the IFZ was associated with their preferential commitment to the early PB linage. Our results reveal a regulatory mechanism of B cell trafficking via an atypical chemokine receptor that shapes activated B cell fate. |
format | Online Article Text |
id | pubmed-5839757 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-58397572018-09-05 Atypical chemokine receptor 4 shapes activated B cell fate Kara, Ervin E. Bastow, Cameron R. McKenzie, Duncan R. Gregor, Carly E. Fenix, Kevin A. Babb, Rachelle Norton, Todd S. Zotos, Dimitra Rodda, Lauren B. Hermes, Jana R. Bourne, Katherine Gilchrist, Derek S. Nibbs, Robert J. Alsharifi, Mohammed Vinuesa, Carola G. Tarlinton, David M. Brink, Robert Hill, Geoffrey R. Cyster, Jason G. Comerford, Iain McColl, Shaun R. J Exp Med Research Articles Activated B cells can initially differentiate into three functionally distinct fates—early plasmablasts (PBs), germinal center (GC) B cells, or early memory B cells—by mechanisms that remain poorly understood. Here, we identify atypical chemokine receptor 4 (ACKR4), a decoy receptor that binds and degrades CCR7 ligands CCL19/CCL21, as a regulator of early activated B cell differentiation. By restricting initial access to splenic interfollicular zones (IFZs), ACKR4 limits the early proliferation of activated B cells, reducing the numbers available for subsequent differentiation. Consequently, ACKR4 deficiency enhanced early PB and GC B cell responses in a CCL19/CCL21-dependent and B cell–intrinsic manner. Conversely, aberrant localization of ACKR4-deficient activated B cells to the IFZ was associated with their preferential commitment to the early PB linage. Our results reveal a regulatory mechanism of B cell trafficking via an atypical chemokine receptor that shapes activated B cell fate. Rockefeller University Press 2018-03-05 /pmc/articles/PMC5839757/ /pubmed/29386231 http://dx.doi.org/10.1084/jem.20171067 Text en © 2018 Kara et al. http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Research Articles Kara, Ervin E. Bastow, Cameron R. McKenzie, Duncan R. Gregor, Carly E. Fenix, Kevin A. Babb, Rachelle Norton, Todd S. Zotos, Dimitra Rodda, Lauren B. Hermes, Jana R. Bourne, Katherine Gilchrist, Derek S. Nibbs, Robert J. Alsharifi, Mohammed Vinuesa, Carola G. Tarlinton, David M. Brink, Robert Hill, Geoffrey R. Cyster, Jason G. Comerford, Iain McColl, Shaun R. Atypical chemokine receptor 4 shapes activated B cell fate |
title | Atypical chemokine receptor 4 shapes activated B cell fate |
title_full | Atypical chemokine receptor 4 shapes activated B cell fate |
title_fullStr | Atypical chemokine receptor 4 shapes activated B cell fate |
title_full_unstemmed | Atypical chemokine receptor 4 shapes activated B cell fate |
title_short | Atypical chemokine receptor 4 shapes activated B cell fate |
title_sort | atypical chemokine receptor 4 shapes activated b cell fate |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839757/ https://www.ncbi.nlm.nih.gov/pubmed/29386231 http://dx.doi.org/10.1084/jem.20171067 |
work_keys_str_mv | AT karaervine atypicalchemokinereceptor4shapesactivatedbcellfate AT bastowcameronr atypicalchemokinereceptor4shapesactivatedbcellfate AT mckenzieduncanr atypicalchemokinereceptor4shapesactivatedbcellfate AT gregorcarlye atypicalchemokinereceptor4shapesactivatedbcellfate AT fenixkevina atypicalchemokinereceptor4shapesactivatedbcellfate AT babbrachelle atypicalchemokinereceptor4shapesactivatedbcellfate AT nortontodds atypicalchemokinereceptor4shapesactivatedbcellfate AT zotosdimitra atypicalchemokinereceptor4shapesactivatedbcellfate AT roddalaurenb atypicalchemokinereceptor4shapesactivatedbcellfate AT hermesjanar atypicalchemokinereceptor4shapesactivatedbcellfate AT bournekatherine atypicalchemokinereceptor4shapesactivatedbcellfate AT gilchristdereks atypicalchemokinereceptor4shapesactivatedbcellfate AT nibbsrobertj atypicalchemokinereceptor4shapesactivatedbcellfate AT alsharifimohammed atypicalchemokinereceptor4shapesactivatedbcellfate AT vinuesacarolag atypicalchemokinereceptor4shapesactivatedbcellfate AT tarlintondavidm atypicalchemokinereceptor4shapesactivatedbcellfate AT brinkrobert atypicalchemokinereceptor4shapesactivatedbcellfate AT hillgeoffreyr atypicalchemokinereceptor4shapesactivatedbcellfate AT cysterjasong atypicalchemokinereceptor4shapesactivatedbcellfate AT comerfordiain atypicalchemokinereceptor4shapesactivatedbcellfate AT mccollshaunr atypicalchemokinereceptor4shapesactivatedbcellfate |